Vir Biotechnology, Inc. VIR Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s change in AP?
- Vir Biotechnology, Inc. (VIR) reported change in AP of -$4.23M in Q1 2026.
- How has Vir Biotechnology, Inc.'s change in AP changed year-over-year?
- Vir Biotechnology, Inc.'s change in AP decreased by 198.7% year-over-year, from -$1.42M to -$4.23M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.